Pharvaris (PHVS) EBT (2020 - 2026)

Pharvaris (PHVS) has 7 years of EBT data on file, last reported at -$45.6 million in Q1 2026.

• Quarterly EBT rose 5.89% year-over-year to -$45.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$192.9 million (down 19.28% YoY) and the FY2025 annual result came in at -$196.3 million, down 36.96% from the prior year.
• EBT rose to -$45.6 million in Q1 2026, from -$52.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$10.5 million in Q2 2022 to a low of -$52.5 million in Q4 2025.
• A 5-year average of -$33.8 million and a median of -$35.6 million in 2023 frame the typical range for EBT.
• The widest YoY moves for EBT: up 42.41% in 2022, down 146.94% in 2022.
• Tracing PHVS's EBT over 5 years: stood at -$40.4 million in 2022, then increased by 11.77% to -$35.6 million in 2023, then declined by 0.56% to -$35.8 million in 2024, then slumped by 46.48% to -$52.5 million in 2025, then rose by 13.14% to -$45.6 million in 2026.
• The last three EBT figures came in at -$45.6 million (Q1 2026), -$52.5 million (Q4 2025), and -$43.6 million (Q3 2025), per Business Quant data.